CD137 antibody (AA 24-186)
-
- Target See all CD137 (TNFRSF9) Antibodies
- CD137 (TNFRSF9) (Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))
-
Binding Specificity
- AA 24-186
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This CD137 antibody is un-conjugated
-
Application
- ELISA, Flow Cytometry (FACS)
- Purpose
- CD137 Antibody
- Purification
- Purified antibody
- Immunogen
- Purified recombinant fragment of human CD137 (AA: 24-186) expressed in E. Coli.
- Clone
- 4G10B9
- Isotype
- IgG1
- Top Product
- Discover our top product TNFRSF9 Primary Antibody
-
-
- Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
- Target
- CD137 (TNFRSF9) (Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))
- Alternative Name
- CD137 (TNFRSF9 Products)
- Background
-
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.
Aliases: TNFRSF9, ILA, 4-1BB, CDw137
- Molecular Weight
- 27.9kDa
- Gene ID
- 3604
- HGNC
- 3604
- UniProt
- Q07011
- Pathways
- Cancer Immune Checkpoints
-